Aravive Biologics

About:

Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways.

Website: http://www.aravive.com/

Twitter/X: AraviveInc

Top Investors: Cancer Prevention and Research Institute of Texas, Invus, Biotechnology Value Fund, Eshelman Ventures

Description:

Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.

Total Funding Amount:

$95.1M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2008-12-10

Contact Email:

Info(AT)aravive.com

Founders:

Amato Giaccia, Jay P. Shepard

Number of Employees:

11-50

Last Funding Date:

2022-10-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai